Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Intimation for Results & Closure of Trading Window

 Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on May 12, 2016 to consider apart from other agenda items to approve the audited financial results for the quarter / year ended on March 31, 2016.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed...
25-04-2016
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016

 Zydus Wellness Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
20-04-2016
Bigul

Shareholding for the Period Ended March 31, 2016

 Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here
06-04-2016
Bigul

FDA nod for Zydus arm's drug

 Drug maker, Cadila Healthcare Limited (Zydus CAdila) on Wednesday informed that Nesher Pharmaceuticals, an arm of Zydus Pharmaceuticals USA has received its first Abbreviated New Drug Application (AN...
30-03-2016
Bigul

Zydus acquires gastro drug 'Actibile' from Kolkata-based Albert David

 This is the Group's second acquisition this year after it had acquired select brands of Zoetis in January
28-03-2016
Bigul

Zydus Pharma Inc recalls 9,504 bottles of Risperidone tablets

 The USFDA said the reason for recall is 'out of specification for a known degradant'
07-03-2016
Bigul

Fixes Record Date for Interim Dividend

 Zydus Wellness Ltd has informed BSE that the Company has fixed March 17, 2016 as the Record Date for the purpose of Payment of Interim Dividend.Further, the interim dividend shall be paid to the shareholders entitled thereto, on and from, March 21, 2016.
04-03-2016
Bigul

Board declares Interim Dividend

 Zydus Wellness Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 04, 2016, has approved payment of interim dividend @ of 65% i.e. Rs. 6.5/- per equity share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the financial year 2015-2016.
04-03-2016
Bigul

Board to consider Interim Dividend

 Zydus Wellness Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 04, 2016, to consider, the proposal for declaration of Interim Dividend, if any, for the financial year 2015-2016 and fixing Record Date for the purpose.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will...
01-03-2016
Bigul

Zydus gets final USFDA nod for anti-diabetic Glyburide, Metformin

 Pharma major Cadila Healthcare Ltd (Zydus Cadila)on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) to market anti-diabetic drugs called ...
01-03-2016
Next Page
Close

Let's Open Free Demat Account